Singapore Translational Cancer Consortium (STCC) joint platform enables collaboration between basic, clinical and translational researchers to explore novel approaches, push promising lines of research and translation, and seed ideas for larger competitive translational grants.
It is now in Phase 1 implementation, focusing on the operationalization of the four platforms: